A new, inexpensive chiral amino alcohol‐based ligand, (1S,2S)‐2‐N,N‐dimethylamino‐1‐(4‐nitrophenyl)‐3‐(tert‐butyloxy)propan‐1‐ol, was developed for the asymmetric alkynylation of chloral in high yield with up to 98% ee. The resulting chiral adduct (S)‐1‐trichloromethyl‐3‐phenyl‐2‐propyn‐1‐ol was hydrogenated over 10% Pd/C to give the useful intermediate chiral trichloromethyl carbinol in quantitative yield, which was efficiently transformed into the pharmaceutically important building blocks 2‐hydroxy‐4‐phenylbutanoate and homophenylalanine in high yield with excellent enantiomeric excess.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: